ID1 and hepatocellular carcinoma: Here, we demonstrate the potential role of BMP9-ID1 signaling in the activation of angiogenesis in HCC cells, and that BMP receptor inhibitors induce an antiangiogenic effect by inhibiting BMP9-ID1 signaling.